August 2013, Nature Review highlights Chan et al paper titled “ Cost-Effectiveness Analysis of Direct-Acting Antiviral Therapy for Treatment-Naive Patients With Chronic Hepatitis C Genotype 1 Infection in the Veterans Health Administration”. Renowned experts on decision-analysis, Gaby Sroczynski & Uwe Siebert, provide their viewpoints.
October 19-21, Society of Medical Decision Making (SMDM) Meeting in Baltimore, Maryland. Dr. Chan will be presenting her research on cost analysis of improving HIV testing strategies.
November 2-6, American Public Health Association (APHA), Dr. Chan will be presenting her research on the cost-effectiveness analysis of mantram therapy in improved health outcomes. Dr. Chan will be co-chairing and moderating the sessions on improving pregnancy outcomes.
Dr. Chan has been selected as the awardee for the Young Professional Award by the Maternal and Child Health (MCH) American Public Health Association. The award ceremony will take place during the Martha May Eliot Luncheon at this year’s APHA Annual Meeting in Boston in November.
EXCITING NEW UPDATES IN CHAN’S LAB:
July 21-25, 2013, International Conference of the System Dynamics Society, to be held in Cambridge, Massachusetts. Dr. Chan and colleagues (Drs. Sheldrick and Pott) were invited to present their paper on “Decision thresholds in developmental-behavioral screening: Gaining insight through system dynamics modeling” at oral presentation panel.
May 5-10, Atlanta, Georgia. Newborn Screening and Genetic Testing Symposium and the International Society for Neonatal Screening. Dr. Chan was invited to attend and meet with stakeholders on the future of newborn screening for severe combined immunodeficiency (SCID), and looking into expansion into Europe, Asia, and Africa.
March 14-17, 2013. Lilly Teaching Conference at Cal Poly Pomona University.
Dr. Chan was invited to give a 90-minute workshop on ‘using social media’ to promote public health education in undergraduate university. This workshop was intended for college and university faculty dedicated to teaching. Integrating the theory of significant learning, Dr. Chan is interested in developing innovative methods to promote inquiry-based learning through the use of internet, social media, and technology.
February 15-18, 2013. Global Health Panelist at Harvard University. Dr. Chan was on a panel discussion on Global Health in Asia at the Harvard Project for Asian and International Relations Conference, held at Harvard University, Cambridge, MA.
January 30, 2013 – LinkedIn Workshop at Boston University.
Dr. Chan hosted a workshop on the basis of LinkedIn, led by Director Terry Brown at Boston University Center for Career Development.
Jan 11, 2013 Friday. Grand Rounds.
Dr. Chan gave a special lecture on cost-effectiveness analysis in health care on immunodeficiency at the Grand Rounds at Medical College of Wisconsin. The event was hosted by Dr. John Routes, the president of the clinical immunology society, and who was the first to adopt Dr. Chan’s Screening test for severe combined immunodeficiency (SCID) to be screened in newborns in Wisconsin since 2009.
Dec 19, 2012 Wednesday 12pm. Dr. Sam Ho invited Dr. Chan to present work on cost-effectivenesss analysis of hepatitis c infection at University of California, San Diego VA Healthcare System.
Dec 12, 2012 Wednesday 12pm-1pm. Dr. Kee Chan presented “Cost-saving drugs for hepatitis c infection” at Sargent College, Room 220. Location: 635 Commonwealth Ave, Boston MA 02215. Time: 12-1:30pm.
Dec 6, 2012 Thursday 10am-11am. Dr. Kee Chan presented at the Agency of Healthcare Research and Quality (AHRQ) in Washington DC, as a part of the seminar series, at 10am. The invitation is sponsored by the Society of Medical Decision Making.
Nov 29, 2012 Thursday 12-1:30pm. Invited speakers, Drs. Kee Chan, Jean Peteet, Ellen Cohn, Sue Berger, and Ms. Danuta Charland on Panel Discussion on “Leading Service Learning in the U.S. and International Countries”. Sargent College, Room 107, 12-1:30pm.
Nov 8, 2012. Dr. Tamas Masszi, Chair of the Education Committee of the European Group of Blood and Marrow Transplantation and the president of the Hungarian Society of Haematologyand Transfusiology, invited Dr. Kee Chan to give a lecture on “newborn screening for severe combined immunodeficiency (SCID)” to the faculty at Semmelweis University. The discussion sparked an international collaboration interest in cost-effectiveness analysis.
Dr. Chan gave an oral presentation on the logic model of genome sequencing at the International Society of Neonatal Screening Regional European meeting.
Oct 2012. In Phoenix, Arizona, Dr. Chan presented her decision-making models to evaluate cost-effectiveness analysis.
Sept 2012. At Boston University (BU), Dr. Chan hosted a workshop on “Financial Management”, led by Rick Shaffer, financial expert and real estate attorney. The event was co-sponsored by the Association for Women in Science (AWIS) and the BU Office of Provost Women in Science and Engineering.
Aug 2012. Dr. Chan presented a webinar on ‘using decision-analytic models for cost-effectiveness analysis’ at the Health Economic Research Center (HERC).
July 2012. Dr. Chan was invited to attend and present at the Health Services Research and Development (HSRD) Conference sponsored by the Veterans Affairs, in Washington DC.
June 2012. In Bethesda, Maryland, Dr. Chan presented her research on bridging science into public health research at the National Institutes of Health (NIH). Dr. Chan presented her research on the ‘cost-effectiveness analysis of hepatitis c treatment at the veterans affairs healthcare system” at the AcademyHealth Meeting in Orlando, Florida.
May 2012. Dr. Chan was invited by Genetic Alliance to attend the meeting held by the Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children in Alexandria, VA.
April 2012. Awarded by the Veterans Affairs Department, Dr. Chan was received grant funding to support her research on cost-effectiveness analysis of hepatitis c treatment and HIV testing.
Jan 2012. Dr. Chan received a teaching grant to develop social media tools to enhance public health education through service learning.
Dec 2011. Dr.Chan is on Consumer Task Force for Newborn Screening funded by Genetic Alliance.
Nov 2011. Dr. Chan presented her research on the “Economic analysis of new Hepatitis C (HCV) medication” at the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) in Madrid, Spain.
Oct 2011. Dr. Chan visited Beijing China. Collaboration on the use of electronic drug monitor (EDM) devices for improving HIV medication adherence.
July 2011. Dr. Chan attended the Genomic Workshop at NIH in Bethesda, MD.
June 2011. Logic modeling behind genome sequencing in newborn screening work presented at the AcademyHealth in Seattle, WA.